Inventor
DUROCHER YVES
CA13 patents
⚠️ This page may combine multiple inventors who share the name “DUROCHER YVES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NAT RES COUNCIL CANADA
8 patentsUS10738115B2Aug 11, 2020
Humanized antibodies transmigrating the blood-brain barrier and uses thereof
NAT RES COUNCIL CANADA2 citations71
US11702466B2Jul 18, 2023
Fusion protein comprising a blood-brain barrier (BBB)-crossing single domain antibody Fc5, an immunoglobulin Fc fragment and a beta-amyloid binding polypeptide (ABP)
NAT RES COUNCIL CANADA1 citations58
US11591408B2Feb 28, 2023
Antibody glycoconjugates and methods of production and use
NAT RES COUNCIL CANADA0 citations57
US10487153B2Nov 26, 2019
Carbonic anhydrase IX-specific antibodies and uses thereof
NAT RES COUNCIL CANADA1 citations55
US12240916B2Mar 4, 2025
Intrabodies for reducing FUT8 activity
NAT RES COUNCIL CANADA0 citations46
US10858629B2Dec 8, 2020
Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
NAT RES COUNCIL CANADA0 citations45
US9353382B2May 31, 2016
Process, vectors and engineered cell lines for enhanced large-scale transfection
NAT RES COUNCIL CANADA0 citations45
US11945858B2Apr 2, 2024
Antibodies and antibody fragments against HNAV1.7 channel and their use in pain and cancer indications
NAT RES COUNCIL CANADA0 citations44
DUROCHER YVES
4 patentsUS8551774B2Oct 8, 2013
Expression vectors containing a truncated epstein barr nuclear antigen 1 lacking the Gly-Gly-Ala domain for enhanced transient gene expression
DUROCHER YVES9 citations80
US8637315B2Jan 28, 2014
Process, vectors and engineered cell lines for enhanced large-scale transfection
DUROCHER YVES4 citations65
US9085627B2Jul 21, 2015
Expression system with SAR element from IFNα2
DUROCHER YVES0 citations48
US10421950B2Sep 24, 2019
Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
DUROCHER YVES0 citations39